Skip to main content

Advertisement

Log in

Novel Common Femoral Artery Lesion Classification in Patients Undergoing Endovascular Revascularization

  • Clinical Investigation
  • Arterial Interventions
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

Common femoral artery (CFA) is a critical segment of the lower-limb arterial tree. We sought to propose an extensive classification in order to appraise a diagnostic and therapeutic approach.

Methods

A retrospective cohort of CFA lesions with endovascular therapy was evaluated. We appraised the extension, the degree of stenosis and the calcium burden. A new group “IV” included lesions that started at the external iliac artery or common iliac artery extending into the CFA and affecting its bifurcation. The primary outcome was the need for a retrograde bailout access after failed anterograde access and the procedural time.

Results

From 2012 to 2020, a total of 58 lower limbs in patients with CFA lesions were included. New proposed group IV compromised 36% of lesions. Additionally, procedural time was significantly longer in group IV lesions compared with the rest (76.9 ± 32.23 min vs 47.67 ± 17.93 min, p < 0.01), as was the requirement of retrograde bailout access (23.8 vs 2.6%, p = 0.03). Occlusive lesions were associated with longer procedural times and bailout retrograde access compared to stenotic lesions (74.7 ± 33.6 min vs 48.29 ± 16 min, p < 0.001 and 26.1 vs 0%, p = 0.006, respectively), as well as heavy calcification compared to mild or moderate calcification (73.18 ± 28.15 vs 51.86 ± 25.1, p = 0.06 and 29.4 vs 2.4%, p = 0.009, respectively). Secondary clinical outcomes and target lesion revascularization did not differ among groups.

Conclusions

Our classification includes a new group of extensive and frequent lesions, which did not fit in previous classifications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kang JL, Patel VI, Conrad MF, Lamuraglia GM, Chung TK, Cambria RP. Common femoral artery occlusive disease: contemporary results following surgical endarterectomy. J Vasc Surg. 2008;48(4):872–7.

    Article  Google Scholar 

  2. Setacci C, de Donato G, Teraa M, Moll FL, Ricco JB, Becker F, et al. Chapter IV: treatment of critical limb ischaemia. Eur J Vasc Endovasc Surg. 2011;42(Suppl 2):S43-59.

    Article  Google Scholar 

  3. Stricker H, Spinedi L, Limoni C, Giovannacci L. Stent-assisted angioplasty (SAA) at the level of the common femoral artery bifurcation: long-term outcomes. Cardiovasc Intervent Radiol. 2020;43:541–6.

    Article  CAS  Google Scholar 

  4. Azéma L, Davaine JM, Guyomarch B, Chaillou P, Costargent A, Patra P, et al. Endovascular repair of common femoral artery and concomitant arterial lesions. Eur J Vasc Endovasc Surg. 2011;41(6):787–93. https://doi.org/10.1016/j.ejvs.2011.02.025 (Epub 2011 Mar 24).

    Article  PubMed  Google Scholar 

  5. Bonvini RF, Rastan A, Sixt S, Noory E, Schwarz T, Frank U, et al. Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures. J Am Coll Cardiol. 2011;58(8):792–8.

    Article  Google Scholar 

  6. Rocha-Singh KJ, Zeller T, Jaff MR. Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv. 2014;83(6):E212–20. https://doi.org/10.1002/ccd.25387 (Epub 2014 Feb 10).

    Article  PubMed  Google Scholar 

  7. Okuno S, Iida O, Shiraki T, Fujita M, Masuda M, Okamoto S, et al. Impact of calcification on clinical outcomes after endovascular therapy for superficial femoral artery disease: assessment using the peripheral artery calcification scoring system. J Endovasc Ther. 2016;23(5):731–7.

    Article  Google Scholar 

  8. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol. 2017;40(8):1141–6.

    Article  CAS  Google Scholar 

  9. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213–60.

    Article  Google Scholar 

  10. Martin R, Vanesa GDC, Raleigh JV, Jose C, Vadim K, Maynar M, Zander T. Common femoral artery stenting: computer tomography angiography based long-term patency. Vasc Endovascular Surg. 2021;55(6):571–6.

    Article  Google Scholar 

  11. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al; Executive group on behalf of the joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) task force for the universal definition of myocardial infarction. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20):e618-e651.

  12. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke. 2018;49(3):e46–110.

    Article  Google Scholar 

  13. Patel MR, Conte MS, Cutlip DE, Dib N, Geraghty P, Gray W, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65(9):931–41.

    Article  Google Scholar 

  14. Nasr B, Della Schiava N, Thaveau F, Rosset E, Favre JP, Salomon du Mont L, et al. The common femoral artery bifurcation lesions: clinical outcome of simple versus complex stenting techniques - an analysis based on the TECCO trial. Ann Vasc Surg. 2020;64:2–10.

  15. Sheeran D, Wilkins LR. Long chronic total occlusions: revascularization strategies. Semin Intervent Radiol. 2018;35(5):469–76.

    Article  Google Scholar 

  16. van der Heijden FH, Eikelboom BC, Banga JD, Mali WP. Management of superficial femoral artery occlusive disease. Br J Surg. 1993;80(8):959–63.

    Article  Google Scholar 

  17. Grözinger G, Hallecker J, Grosse U, Syha R, Ketelsen D, Brechtel K, et al. Tibiopedal and distal femoral retrograde vascular access for challenging chronic total occlusions: predictors for technical success, and complication rates in a large single-center cohort. Eur Radiol. 2021;31(1):535–42.

    Article  Google Scholar 

  18. Giannopoulos S, Palena LM, Armstrong EJ. Technical success and complication rates of retrograde arterial access for endovascular therapy for critical limb ischaemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2021;61(2):270–9.

    Article  Google Scholar 

  19. Boufi M, Ejargue M, Gaye M, Boyer L, Alimi Y, Loundou AD. Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment. J Vasc Surg. 2021;73(4):1445–55.

    Article  Google Scholar 

  20. Guo J, Guo L, Tong Z, Gao X, Wang Z, Gu Y. Directional atherectomy is associated with better long-term efficiency compared with angioplasty for common femoral artery occlusive disease in Rutherford 2–4 patients. Ann Vasc Surg. 2018;51:65–71.

    Article  Google Scholar 

  21. Cantu D, Jawaid O, Kokkinidis D, Giannopoulos S, Valle JA, Waldo SW, Singh GD, Armstrong EJ. outcomes of drug-coated balloon angioplasty vs. conventional balloon angioplasty for endovascular treatment of common femoral artery atherosclerotic disease. Cardiovasc Revasc Med. 2020; 21(7):867–874.

  22. Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, Bollenberg L, Bisdas T. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther. 2018;25(1):92–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Juan Valle Raleigh.

Ethics declarations

Conflict of interest

The author(s) declared no potential conflict of interest with respect to the research, authorship and/or publication of this article.

Ethical Approval

The manuscript was approved by the Ethics committee of our Hospital.

Informed Consent

Informed consent was obtained in all patients.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 16 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rabellino, M., Valle Raleigh, J., Chiabrando, J.G. et al. Novel Common Femoral Artery Lesion Classification in Patients Undergoing Endovascular Revascularization. Cardiovasc Intervent Radiol 45, 438–447 (2022). https://doi.org/10.1007/s00270-021-03011-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-021-03011-z

Keywords

Navigation